Acinetobacter baumannii is a multidrug resistant pathogen that infects more than 12 000 patients each year in the US. Much of the resistance to β-lactam antibiotics in Acinetobacter spp. is mediated by class C β-lactamases known as Acinetobacter-derived cephalosporinases (ADCs). ADCs are unaffected by clinically used β-lactam-based β-lactamase inhibitors. In this study, five boronic acid transition state analog inhibitors (BATSIs) were evaluated for inhibition of the class C cephalosporinase ADC-7. Our goal was to explore the properties of BATSIs designed to probe the R1 binding site. Kivalues ranged from low micromolar to subnanomolar, and circular dichroism (CD) demonstrated that each inhibitor stabilizes the β-lactamase-inhibitor complexes. Additionally, X-ray crystal structures of ADC-7 in complex with five inhibitors were determined (resolutions from 1.80 to 2.09 Å). In the ADC-7/CR192 complex, the BATSI with the lowest Ki(0.45 nM) and greatest ΔTm(+9 °C), a trifluoromethyl substituent, interacts with Arg340. Arg340 is unique to ADCs and may play an important role in the inhibition of ADC-7. The ADC-7/BATSI complexes determined in this study shed light into the unique recognition sites in ADC enzymes and also offer insight into further structure-based optimization of these inhibitors.

Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase / Bouza, Alexandra A; Swanson, Hollister C; Smolen, Kali A; Vandine, Alison L; Taracila, Magdalena A; Romagnoli, Chiara; Caselli, Emilia; Prati, Fabio; Bonomo, Robert A; Powers, Rachel A; Wallar, Bradley J. - In: ACS INFECTIOUS DISEASES. - ISSN 2373-8227. - (2018), pp. 325-336. [10.1021/acsinfecdis.7b00152]

Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase

Romagnoli, Chiara;Caselli, Emilia;Prati, Fabio;
2018

Abstract

Acinetobacter baumannii is a multidrug resistant pathogen that infects more than 12 000 patients each year in the US. Much of the resistance to β-lactam antibiotics in Acinetobacter spp. is mediated by class C β-lactamases known as Acinetobacter-derived cephalosporinases (ADCs). ADCs are unaffected by clinically used β-lactam-based β-lactamase inhibitors. In this study, five boronic acid transition state analog inhibitors (BATSIs) were evaluated for inhibition of the class C cephalosporinase ADC-7. Our goal was to explore the properties of BATSIs designed to probe the R1 binding site. Kivalues ranged from low micromolar to subnanomolar, and circular dichroism (CD) demonstrated that each inhibitor stabilizes the β-lactamase-inhibitor complexes. Additionally, X-ray crystal structures of ADC-7 in complex with five inhibitors were determined (resolutions from 1.80 to 2.09 Å). In the ADC-7/CR192 complex, the BATSI with the lowest Ki(0.45 nM) and greatest ΔTm(+9 °C), a trifluoromethyl substituent, interacts with Arg340. Arg340 is unique to ADCs and may play an important role in the inhibition of ADC-7. The ADC-7/BATSI complexes determined in this study shed light into the unique recognition sites in ADC enzymes and also offer insight into further structure-based optimization of these inhibitors.
2018
8-dic-2017
325
336
Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase / Bouza, Alexandra A; Swanson, Hollister C; Smolen, Kali A; Vandine, Alison L; Taracila, Magdalena A; Romagnoli, Chiara; Caselli, Emilia; Prati, Fabio; Bonomo, Robert A; Powers, Rachel A; Wallar, Bradley J. - In: ACS INFECTIOUS DISEASES. - ISSN 2373-8227. - (2018), pp. 325-336. [10.1021/acsinfecdis.7b00152]
Bouza, Alexandra A; Swanson, Hollister C; Smolen, Kali A; Vandine, Alison L; Taracila, Magdalena A; Romagnoli, Chiara; Caselli, Emilia; Prati, Fabio; Bonomo, Robert A; Powers, Rachel A; Wallar, Bradley J
File in questo prodotto:
File Dimensione Formato  
Revised Manuscript.pdf

Open access

Descrizione: Articolo principale
Tipologia: Versione dell'autore revisionata e accettata per la pubblicazione
Dimensione 1.59 MB
Formato Adobe PDF
1.59 MB Adobe PDF Visualizza/Apri
bouza2018.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 6.73 MB
Formato Adobe PDF
6.73 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1157540
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 27
  • ???jsp.display-item.citation.isi??? 24
social impact